but wasn't sure how far that would go and dismissed it. And that was because of the push for similar drugs such as hydroxychloroquine, which has also been used "for decades safely" too - but for specific indications (not just as an anti-parasitic but for people who have lupus). And limits for specific indications need to apply to this as well.
I.e., something might be "approved" for something, but needs to await enough peer-reviewed research over time, and an application for an EUA, in order to gain approval for other indications.
What I am saying is that this coronavirus is NOVEL. We don't have decades worth of data for what would basically be an "off label" use of a product normally prescribed as an anti-parasitic, and apply it to viruses (particularly since viruses are constantly mutating). COVID-19 has only been identified for just over a year, so it will take time to see what is "effective" considering that other viruses have little or no prophylactic treatments (i.e., "coronaviruses" are part of a class of viruses that appear alongside rhinoviruses for what we often call "the common cold" ), where an example of attempts at a push for prophylactics for such has been the use of Zinc (like in Cold-Eze) to supposedly reduce symptoms.
And as a note "NIH approval" is NOT "FDA approval". NIH doesn't approve drugs or biologics for human use. FDA does.
FDA's FAQ about this notes this -
They also reference this -
https://www.fda.gov/animal-veterinary/product-safety-information/faq-covid-19-and-ivermectin-intended-animals
Much of the research initially began with the precursor SARS-CoV-1 (almost 20 years ago) and it's good that so many researchers are looking at every aspect and every way to treat this, because whatever they ultimately come up with may truly be able to help with something as simple as "the common cold". But just keep in mind that right now, it all comes down to "risk/benefit".
= new reply since forum marked as read